European Union

Eir Ventures Closes Life Science Venture Fund at EUR122 million

Retrieved on: 
Thursday, December 9, 2021

STOCKHOLM and COPENHAGEN, Denmark, Dec. 9, 2021 /PRNewswire/ -- Eir Ventures Partners AB ("Eir Ventures" or "the Fund"), a Nordic Life Science Venture Capital manager, today announced the final close of its fund Eir Ventures I AB of EUR 122.3 million.

Key Points: 
  • STOCKHOLM and COPENHAGEN, Denmark, Dec. 9, 2021 /PRNewswire/ -- Eir Ventures Partners AB ("Eir Ventures" or "the Fund"), a Nordic Life Science Venture Capital manager, today announced the final close of its fund Eir Ventures I AB of EUR 122.3 million.
  • The fund invests in innovative life science companies with products and technologies addressing significant unmet medical needs.
  • Dr Magnus PerssonMD PhD, Founding Partner and Chairman of Eir Ventures, added,"We thank our loyal and new investors for their trust in Eir Ventures.
  • Eir Ventures is a life science focused venture fund, that with a strong foundation in the Nordic Biotech ecosystem invests in early stage as well as more mature opportunities.

Eir Ventures Closes Life Science Venture Fund at EUR122 million

Retrieved on: 
Thursday, December 9, 2021

STOCKHOLM and COPENHAGEN, Denmark, Dec. 9, 2021 /PRNewswire/ -- Eir Ventures Partners AB ("Eir Ventures" or "the Fund"), a Nordic Life Science Venture Capital manager, today announced the final close of its fund Eir Ventures I AB of EUR 122.3 million.

Key Points: 
  • Two portfolio companies IPO'ed on NASDAQ New York
    STOCKHOLM and COPENHAGEN, Denmark, Dec. 9, 2021 /PRNewswire/ -- Eir Ventures Partners AB ("Eir Ventures" or "the Fund"), a Nordic Life Science Venture Capital manager, today announced the final close of its fund Eir Ventures I AB of EUR 122.3 million.
  • The fund invests in innovative life science companies with products and technologies addressing significant unmet medical needs.
  • Dr Magnus PerssonMD PhD, Founding Partner and Chairman of Eir Ventures, added,"We thank our loyal and new investors for their trust in Eir Ventures.
  • Eir Ventures is a life science focused venture fund, that with a strong foundation in the Nordic Biotech ecosystem invests in early stage as well as more mature opportunities.

Finblox, a High-Yield Digital Asset Savings Platform by Y Combinator Alum and Coins.ph CTO, Raises Seven-Digit Round From Sequoia Capital India, MSA, Venturra, Coinfund, Saison

Retrieved on: 
Thursday, December 9, 2021

Finblox , a global crypto investment platform, has announced seven-digit funding from Sequoia Capital India , MSA Capital , Venturra Discovery , Coinfund , Saison Capital , Ratio Ventures and First Check Ventures .

Key Points: 
  • Finblox , a global crypto investment platform, has announced seven-digit funding from Sequoia Capital India , MSA Capital , Venturra Discovery , Coinfund , Saison Capital , Ratio Ventures and First Check Ventures .
  • A bridge between cryptocurrencies and traditional financial and wealth management products is required to onboard individual investors into the overall digital asset ecosystem.
  • Currently, the app offers up to 10% Annual Percentage Yield on USD Coin and BTC, with payouts distributed daily.
  • Saison Capital is a corporate venture capital arm of Credit Saison, a Tokyo-listed $30B AUM consumer finance company and one of the largest credit card issuers in Japan.

Travel Restrictions on African Nations Demonstrate the Need for Second Citizenship as a Plan B, Families Look to St Kitts and Nevis

Retrieved on: 
Thursday, December 9, 2021

LONDON, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The spread of the latest COVID variant – Omicron – has proven that we are still far from the end of the pandemic. Though the variant’s origins are still unclear, it was first identified in South Africa but has since spread to various regions of the world.

Key Points: 
  • These bans have sparked outrage amongst African leaders who argue that travel restrictions do not solve the problem and only harm the economies of developing nations already struggling from the fallout of the pandemic.
  • Second citizenship helps those that want to position themselves globally without the fear that their country of origin will hold them back.
  • Originating in St Kitts and Nevis , the Caribbean nation is considered the industrys Platinum Standard brand.
  • St Kitts and Nevis also offers alternative business prospects in one of the fastest-growing economies in the region with ties to financial superpowers like the United States.

Biolidics to Commence Commercial Production of its ClearEpi SARS-COV-2 Neutralising Antibody Rapid Test Kit

Retrieved on: 
Wednesday, December 8, 2021

The ClearEpi NAB Test was developed by Biolidics with technology licensed from A*STAR's A*ccelerate.

Key Points: 
  • The ClearEpi NAB Test was developed by Biolidics with technology licensed from A*STAR's A*ccelerate.
  • The clinical validation of the ClearEpi NAB Test was undertaken in Singapore.
  • Biolidics engaged A*STAR Infectious Disease Labs (ID Labs) for the screening of the prototype, as part of the clinical validation of the ClearEpi NAB Test conducted by Biolidics.
  • Most commercially available serology tests against COVID-19, including the Company's COVID-19 Antibody Test Kit launched on 30 March 2020, test for the presence of IgM/IgG antibodies.

U.S. Global Investors Announces Record Net Income of $32 Million in Fiscal Year 2021, Continuation of Dividends

Retrieved on: 
Wednesday, December 8, 2021

Net income for the 12-month period was $32.0 million, or $2.12 per share, compared to a net loss of $4.7 million, or $0.31 loss per share, a year earlier.

Key Points: 
  • Net income for the 12-month period was $32.0 million, or $2.12 per share, compared to a net loss of $4.7 million, or $0.31 loss per share, a year earlier.
  • For the quarter, net income was $4.7 million, an increase of 217% from the same three-month period a year ago.
  • Earnings from operations were $8.2 million and investment income was $28.3 million.
  • Dividends totaling $552,000 and $88,000 were paid to holders of class A and class C common stock, respectively, in fiscal year 2021.

President and CEO Judy Marks Elected as Chair of Otis Worldwide Corporation

Retrieved on: 
Wednesday, December 8, 2021

FARMINGTON, Conn., Dec. 8, 2021 /PRNewswire/ -- Otis Worldwide Corp. (NYSE: OTIS), the world's leading company for elevator and escalator manufacturing, installation and service, today announced thatits Board of Directors has elected Judy Marks as its Chair, effective February 3, 2022.

Key Points: 
  • FARMINGTON, Conn., Dec. 8, 2021 /PRNewswire/ -- Otis Worldwide Corp. (NYSE: OTIS), the world's leading company for elevator and escalator manufacturing, installation and service, today announced thatits Board of Directors has elected Judy Marks as its Chair, effective February 3, 2022.
  • Marks will also continue in her current role as President and Chief Executive Officer of Otis, a role she has held since June 2019.
  • She will succeed Chris Kearney who has served as Executive Chair since Otis became an independent, publicly traded company in April 2020.
  • The combination of the offices of President and CEO and Chair of the Board underscores the Board's confidence in Marks, Otis and the extended Otis team.

Navitas Opens New Design Center Focused on Enabling GaN-based Data-Centers

Retrieved on: 
Wednesday, December 8, 2021

Data center power customers will be supported worldwide by the new team, from concept to prototype, through to full qualification and mass production.

Key Points: 
  • Data center power customers will be supported worldwide by the new team, from concept to prototype, through to full qualification and mass production.
  • The Design Center will develop schematics, layouts, and firmware for full-function, productizable data center power supplies.
  • "The Navitas Data Center team has the new technical skills of GaN power ICs plus the experience of real power supply design and qualification," said Charles ZHA, VP and GM of Navitas China.
  • Navitas Semiconductor, GaNFast and the Navitas logo are trademarks or registered trademarks of Navitas Semiconductor.

PyroGenesis Announces the Launch of a New ZCE Hydrogen Production Process Following the Filing of International Patent Applications

Retrieved on: 
Wednesday, December 8, 2021

PyroGenesis new hydrogen production technology is now entering a testing phase and is expected to convert methane (a GHG with a high global warming potential) to hydrogen, thereby creating a ZCE hydrogen.

Key Points: 
  • PyroGenesis new hydrogen production technology is now entering a testing phase and is expected to convert methane (a GHG with a high global warming potential) to hydrogen, thereby creating a ZCE hydrogen.
  • The conventional ZCE process, water electrolysis, is extremely expensive, requires a lot of energy and uses rare earth materials.
  • PyroGenesis new technology is expected to combine the best of both worlds; it is expected to be cheaper than any existing hydrogen process while at the same time producing ZCE hydrogen.
  • We believe our new proprietary hydrogen production process will be much more energy efficient, cost-effective and scalable than other forms of hydrogen production.

Chainguard Raises $5 Million From Amplify Partners to Fix Software Supply-Chain Security

Retrieved on: 
Wednesday, December 8, 2021

The founding team of five open-source veterans isDan Lorenc, Matt Moore, Scott Nichols, Ville Aikas, and Kim Lewandowski.

Key Points: 
  • The founding team of five open-source veterans isDan Lorenc, Matt Moore, Scott Nichols, Ville Aikas, and Kim Lewandowski.
  • The industry has been hit hard with a wrath of software supply chain attacks over the past few years, especially attacks targeting open source software.
  • Nearly every piece of software has "dependencies," often other open-source libraries that the project is built on.
  • Lenny Pruss, General Partner atAmplify, commented: "In the last 12 months, we've witnessed software supply chain security become the top priority for security practitioners and buyers.